472 related articles for article (PubMed ID: 25433728)
21. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients.
Baiocchi GL; Tiberio GA; Minicozzi AM; Morgagni P; Marrelli D; Bruno L; Rosa F; Marchet A; Coniglio A; Saragoni L; Veltri M; Pacelli F; Roviello F; Nitti D; Giulini SM; De Manzoni G
Ann Surg; 2010 Jul; 252(1):70-3. PubMed ID: 20562605
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
24. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
25. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
26. Predictors of long-term survival in pN3 gastric cancer patients.
Kim J; Cheong JH; Hyung WJ; Shen J; Choi SH; Noh SH
J Surg Oncol; 2004 Oct; 88(1):9-13. PubMed ID: 15384089
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
Yamashita H; Deng J; Liang H; Seto Y
Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
[TBL] [Abstract][Full Text] [Related]
29. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
30. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
31. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
[TBL] [Abstract][Full Text] [Related]
33. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
Isozaki H; Tanaka N; Okajima K
Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival analysis of gastric cancer limited to the subserosa.
Lisborg PH; Jatzko GR; Denk H; Klimpfinger MH; Stettner HM
Z Gastroenterol; 1997 Sep; 35(9):663-8. PubMed ID: 9360292
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
36. Lymph node metastasis in gastric cancer in the upper third of the stomach--surgical treatment on the basis of the anatomical distribution of positive node.
Kitamura K; Nishida S; Yamamoto K; Ichikawa D; Okamoto K; Taniguchi H; Yamaguchi T; Sawai K; Takahashi T
Hepatogastroenterology; 1998; 45(19):281-5. PubMed ID: 9496527
[TBL] [Abstract][Full Text] [Related]
37. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]